Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Appropriately aggregate holistic technologies via accurate expertise. Intrinsicly strategize worldwide initiatives and premium methodologies.

Antibody evasion by the P.1 strain of SARS-CoV-2

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2939 - 2954.e9

Evidence of escape of SARS-CoV-2 variant B.1.351 from natural and vaccine-induced sera

Journal article

Zhou D. et al, (2021), Cell, 184, 2348 - 2361.e6

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

Journal article

Supasa P. et al, (2021), Cell, 184, 2201 - 2211.e7

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Journal article

Dejnirattisai W. et al, (2021), Cell, 184, 2183 - 2200.e22

Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel

Journal article

Adams ER. et al, (2020), Wellcome Open Research, 5, 139 - 139

Drug-cured experimental Trypanosoma cruzi infections confer long-lasting and cross-strain protection.

Journal article

Mann GS. et al, (2020), PLoS neglected tropical diseases, 14

Antibody testing for COVID-19: A report from the National COVID Scientific Advisory Panel.

Journal article

Adams ER. et al, (2020), Wellcome open research, 5

Production and Purification of Zika Virus NS1 Glycoprotein in HEK293 Cells.

Journal article

Kim YC. et al, (2020), Methods in molecular biology (Clifton, N.J.), 2142, 93 - 102

Load More